These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24147515)

  • 21. [Drug-induced cardiac arrest maybe more common than believed].
    Abdon NJ; Herlitz J; Bergfeldt L
    Lakartidningen; 2010 Feb 24-Mar 2; 107(8):521-2, 524-5. PubMed ID: 20384063
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acquired long QT syndrome and cardiac arrest after general anesthesia. Case report and review of literature].
    Leclercq T; Parrel S; Mierdl S; Cottin Y; Girard C
    Ann Fr Anesth Reanim; 2014 Jun; 33(6):421-6. PubMed ID: 24880555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation.
    Niedrig D; Maechler S; Hoppe L; Corti N; Kovari H; Russmann S
    Eur J Clin Pharmacol; 2016 Jul; 72(7):859-67. PubMed ID: 27023463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired long QT syndrome: long-term electrocardiographic (Holter) recording of torsades de pointes ending in asystole: II.
    Raviña T; Gutierrez J; Raviña P
    Int J Cardiol; 2007 Mar; 116(2):272-5. PubMed ID: 16859777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia.
    Hayashi Y; Ikeda U; Hashimoto T; Watanabe T; Mitsuhashi T; Shimada K
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):672-4. PubMed ID: 10234723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
    Pearson EC; Woosley RL
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of cardiac arrest after torsades de pointes due to prolonged QT interval syndrome possibly associated with subarachnoid hemorrhage].
    Yamaguchi S; Watanabe K; Mishio M; Okuda Y; Kitajima T
    Masui; 1999 Jun; 48(6):644-6. PubMed ID: 10402818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
    Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
    Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
    Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
    Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.
    Kezerashvili A; Khattak H; Barsky A; Nazari R; Fisher JD
    J Interv Card Electrophysiol; 2007 Apr; 18(3):243-6. PubMed ID: 17546486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torsades de Pointes with QT prolongation related to donepezil use.
    Takaya T; Okamoto M; Yodoi K; Hata K; Kijima Y; Nakajima H; Nishikawa Y; Kita T; Ito M; Seo T; Kawashima S
    J Cardiol; 2009 Dec; 54(3):507-11. PubMed ID: 19944332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
    Letsas KP; Filippatos GS; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Cardiology; 2006; 105(3):146-7. PubMed ID: 16449812
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors.
    Letsas KP; Efremidis M; Kounas SP; Pappas LK; Gavrielatos G; Alexanian IP; Dimopoulos NP; Filippatos GS; Sideris A; Kardaras F
    Clin Res Cardiol; 2009 Apr; 98(4):208-12. PubMed ID: 19031039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced long QT syndrome in women.
    Li G; Cheng G; Wu J; Zhou X; Liu P; Sun C
    Adv Ther; 2013 Sep; 30(9):793-802. PubMed ID: 24085659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QT prolongation and Torsades de Pointes associated with clarithromycin.
    Lee KL; Jim MH; Tang SC; Tai YT
    Am J Med; 1998 Apr; 104(4):395-6. PubMed ID: 9576415
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
    Aström-Lilja C; Odeberg JM; Ekman E; Hägg S
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):587-92. PubMed ID: 18449951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol].
    Guy JM; André-Fouet X; Porte J; Bertrand M; Lamaud M; Verneyre H
    Ann Cardiol Angeiol (Paris); 1991 Nov; 40(9):541-5. PubMed ID: 1776799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.